CHGCF
Price:
$45.93
Market Cap:
$12.43T
Chugai Pharmaceutical Co., Ltd. is a Japan-headquartered global biopharmaceutical firm, engaged in the entire process of pharmaceutical product creation, from groundbreaking research and development to manufacturing, marketing, and worldwide distribution. Its extensive product portfolio targets critical health areas. In oncology, key offerings include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva. For osteoporosis, it provides Actemra, Edirol, and Bonviva. Other specialized medications address conditions such as erythropoiesis (Mircera) and secondary hyperparathyroidism (Oxarol). Furthermore, Chugai offers treatments like Hem...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2012-08-03
Stock Exchange
OTC
Ticker
CHGCF
Dividends are a key part of long-term returns for investors, and Chugai Pharmaceutical Co., Ltd. (CHGCF) has a track record worth reviewing. Looking at dividend history for CHGCF gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2026-12-31
Dividend Yield
3.60%
Annual Dividend
$0.43
P/E Ratio
27.84
Payout Ratio
0.99
Dividend per Share
$272.00
EPS
1.65
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2026-12-31 | $0.4319 | $0.4319 | 2026-01-29 | |
| 2026-06-30 | $0.4319 | $0.4319 | 2026-08-28 | 2026-01-29 |
| 2025-12-31 | $0.9378 | $0.9378 | 2026-03-27 | 2025-01-30 |
| 2025-06-30 | $0.867 | $0.867 | 2025-08-28 | 2025-01-30 |
| 2024-12-31 | $0.3627 | $0.3627 | 2025-03-28 | 2024-02-01 |
| 2024-06-28 | $0.2548 | $0.2548 | 2024-08-29 | 2024-02-01 |
| 2023-12-28 | $0.2837 | $0.28272 | 2024-03-29 | 2023-02-02 |
| 2023-06-29 | $0.2764 | $0.277 | 2023-08-30 | 2023-02-02 |
| 2022-12-29 | $0.3032 | $0.283 | 2023-03-31 | 2022-02-03 |
| 2022-06-29 | $0.2784 | $0.279 | 2022-08-30 | 2022-02-03 |
| 2021-12-29 | $0.3995 | $0.401 | 2022-03-30 | 2021-02-04 |
The table below shows Chugai Pharmaceutical Co., Ltd. (CHGCF) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Chugai Pharmaceutical Co., Ltd. (CHGCF) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|---|
| GSK plc (GLAXF) | 0.03% |
| Daiichi Sankyo Company, Limited (DSNKY) | 0.03% |
| Daiichi Sankyo Company, Limited (DSKYF) | 0.03% |
| Siemens Healthineers AG (SEMHF) | 0.03% |
| Merck KGaA (MKGAF) | 0.02% |
| Merck KGaA (MKKGY) | 0.02% |
| Sartorius AG (SOAGY) | 0.00% |
| CSL Limited (CMXHF) | 0.04% |
| HOYA Corporation (HOCPY) | 0.01% |
| Ipsen S.A. (IPSEY) | 0.01% |
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Chugai Pharmaceutical Co., Ltd. (CHGCF) without the pain and hassle of copy pasting data.
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is CHGCF’s dividend yield?
What is the difference between regular and special dividends?
Has CHGCF increased its dividends over time?
Why might dividend history data be delayed?
How often does CHGCF pay dividends?
What factors impact CHGCF's dividend payments?
Can dividends change over time?
What is CHGCF’s next dividend date?